Requirements for Human Medical Genome Testing Utilising Massively Parallel Sequencing Technologies (First Edition 2017)

This is a publication of the National Pathology Accreditation Advisory Council (NPAAC) which is managed by the Australian Government Department of Health

Page last updated: 09 March 2017

The Requirements for Human Medical Genome Testing Utilising Massively Parallel Sequencing Technologies (First Edition 2017) outlines the minimum best practice requirements for medical pathology laboratories undertaking the performance and implementation of human genetic testing utilising massively parallel sequencing (MPS) for all applications (ie. single gene, panel of genes, somatic testing, whole exome or whole genome or non-invasive prenatal screening) also known as next generation sequencing. It takes a risk based approach to defining standards for the implementation of these new technologies.

This document has a proposed date of effect of 2 April 2017.

Requirements for Human Medical Genome Testing Utilising Massively Parallel Sequencing Technologies (First Edition 2017) (PDF 213 KB)
Requirements for Human Medical Genome Testing Utilising Massively Parallel Sequencing Technologies (First Edition 2017) (Word 131 KB)

Should you have any queries, please contact the NPAAC Secretariat.